| Year |
Citation |
Score |
| 2024 |
Shibahara Y, Delabie JMA, Kulkarni S, Grant A, Prica A, McCready DR, Done SJ. Primary MALT lymphoma of the breast: pathological and radiological characteristics. Breast Cancer Research and Treatment. PMID 38427311 DOI: 10.1007/s10549-024-07258-1 |
0.319 |
|
| 2024 |
Dy A, Nguyen NJ, Meyer J, Dawe M, Shi W, Androutsos D, Fyles A, Liu FF, Done S, Khademi A. AI improves accuracy, agreement and efficiency of pathologists for Ki67 assessments in breast cancer. Scientific Reports. 14: 1283. PMID 38218973 DOI: 10.1038/s41598-024-51723-2 |
0.318 |
|
| 2021 |
Done SJ, Kanwar N, Balde Z, Nair R, Dawe M, Chen S, Maganti M, Atenafu EG, Manolescu S, Wei CX, Mao A, Fu F, Wang D, Cheung A, Yerofeyeva Y, et al. Heterogeneity of circulating tumor cell-associated genomic gains in breast cancer and its association with the host immune response. Cancer Research. PMID 34711609 DOI: 10.1158/0008-5472.CAN-21-1079 |
0.426 |
|
| 2021 |
El Ghamrasni S, Quevedo R, Hawley J, Mazrooei P, Hanna Y, Cirlan I, Zhu H, Bruce JP, Oldfield LE, Yang SYC, Guilhamon P, Reimand J, Cescon DW, Done SJ, Lupien M, et al. Mutations in Noncoding -Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast Cancer. Molecular Cancer Research : McR. PMID 34556523 DOI: 10.1158/1541-7786.MCR-21-0471 |
0.415 |
|
| 2021 |
Jaiswal A, Murakami K, Elia A, Shibahara Y, Done SJ, Wood SA, Donato NJ, Ohashi PS, Reedijk M. Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34518219 DOI: 10.1073/pnas.2101592118 |
0.305 |
|
| 2021 |
Schachter NF, Adams JR, Skowron P, Kozma KJ, Lee CA, Raghuram N, Yang J, Loch AJ, Wang W, Kucharczuk A, Wright KL, Quintana RM, An Y, Dotzko D, Gorman JL, ... ... Done SJ, et al. Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer. Nature Communications. 12: 5238. PMID 34475389 DOI: 10.1038/s41467-021-25467-w |
0.337 |
|
| 2021 |
Kozma KJ, Done SJ, Egan SE. The tumor cell-derived matrix of lobular breast cancer: a new vulnerability. Embo Molecular Medicine. 13: e13807. PMID 33616312 DOI: 10.15252/emmm.202013807 |
0.407 |
|
| 2020 |
Li BB, Scott EY, Chamberlain MD, Duong BTV, Zhang S, Done SJ, Wheeler AR. Cell invasion in digital microfluidic microgel systems. Science Advances. 6: eaba9589. PMID 32832633 DOI: 10.1126/Sciadv.Aba9589 |
0.366 |
|
| 2020 |
Wu Q, Ba-Alawi W, Deblois G, Cruickshank J, Duan S, Lima-Fernandes E, Haight J, Tonekaboni SAM, Fortier AM, Kuasne H, McKee TD, Mahmoud H, Kushida M, Cameron S, Dogan-Artun N, ... ... Done SJ, et al. GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer. Nature Communications. 11: 4205. PMID 32826891 DOI: 10.1038/S41467-020-18020-8 |
0.349 |
|
| 2020 |
Al-Arnawoot B, Scaranelo A, Fleming R, Kulkarni S, Menezes RJ, McCready D, Done S, Freitas V. Cellular fibroepithelial lesions diagnosed on core needle biopsy: Is there any role of clinical-sonography features helping to differentiate fibroadenomas and phyllodes tumor? Journal of Surgical Oncology. PMID 32396665 DOI: 10.1002/Jso.25977 |
0.349 |
|
| 2020 |
Kanwar N, Carmine-Simmen K, Nair R, Wang C, Moghadas-Jafari S, Blaser H, Tran-Thanh D, Wang D, Wang P, Wang J, Pasculescu A, Datti A, Mak T, Lewis JD, Done SJ. Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis. Ebiomedicine. 52: 102646. PMID 32062352 DOI: 10.1016/J.Ebiom.2020.102646 |
0.347 |
|
| 2020 |
Romero JM, Grünwald BT, Jang GH, Bavi PP, Jhaveri A, Masoomian M, Fischer SE, Zhang A, Denroche RE, Lungu IM, De Luca A, Bartlett JMS, Xu J, Li N, Dhaliwal S, ... ... Done SJ, et al. A four-chemokine signature is associated with a T cell-inflamed phenotype in primary and metastatic pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31964786 DOI: 10.1158/1078-0432.Ccr-19-2803 |
0.302 |
|
| 2019 |
Lourenco C, Kalkat M, Houlahan KE, De Melo J, Longo J, Done SJ, Boutros PC, Penn LZ. Modelling the MYC-driven normal-to-tumour switch in breast cancer. Disease Models & Mechanisms. 12. PMID 31350286 DOI: 10.1242/Dmm.038083 |
0.416 |
|
| 2019 |
Chiarelli AM, Blackmore KM, Mirea L, Done SJ, Majpruz V, Weerasinghe A, Rabeneck L, Muradali D. Annual versus biennial screening: diagnostic accuracy among concurrent cohorts within the Ontario Breast Screening Program. Journal of the National Cancer Institute. PMID 31233138 DOI: 10.1093/Jnci/Djz131 |
0.417 |
|
| 2019 |
Mrkonjic M, Berman HK, Done SJ, Youngson B, Mulligan AM. Breast specimen handling and reporting in the post-neoadjuvant setting: challenges and advances. Journal of Clinical Pathology. 72: 120-132. PMID 30670564 DOI: 10.1136/jclinpath-2018-205598 |
0.338 |
|
| 2017 |
Abdalla M, Tran-Thanh D, Moreno J, Iakovlev V, Nair R, Kanwar N, Abdalla M, Lee JPY, Kwan JYY, Cawthorn TR, Warren K, Arneson N, Wang DY, Fox NS, Youngson BJ, ... ... Done SJ, et al. Mapping genomic and transcriptomic alterations spatially in epithelial cells adjacent to human breast carcinoma. Nature Communications. 8: 1245. PMID 29093438 DOI: 10.1038/s41467-017-01357-y |
0.401 |
|
| 2017 |
Rakovitch E, Nofech-Mozes S, Hanna W, Sutradhar R, Gu S, Fong C, Tuck A, Youngson B, Miller N, Done SJ, Chang MC, Sengupta S, Elavathil L, Jani PA, Bonin M, et al. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy. Breast (Edinburgh, Scotland). PMID 28781102 DOI: 10.1016/j.breast.2017.07.002 |
0.308 |
|
| 2017 |
Kanwar N, Done SJ. Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures. Advances in Experimental Medicine and Biology. 994: 143-167. PMID 28560673 DOI: 10.1007/978-3-319-55947-6_8 |
0.424 |
|
| 2016 |
Lowes LE, Bratman SV, Dittamore R, Done S, Kelley SO, Mai S, Morin RD, Wyatt AW, Allan AL. Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation. International Journal of Molecular Sciences. 17. PMID 27618023 DOI: 10.3390/Ijms17091505 |
0.339 |
|
| 2016 |
Valic, Leong W, Done S, Wilson B, Kulkarni S, McCready, Niu C, Atachia Y, Munro E, Rempel D. Abstract P4-03-05: Wide-field optical coherence tomography (WF-OCT) for near real-time, point-of-care assessment of margin status in breast-conserving surgery specimens: Results of a feasibility study at a high-volume single-centre Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P4-03-05 |
0.404 |
|
| 2015 |
Chiarelli AM, Prummel MV, Muradali D, Shumak RS, Majpruz V, Brown P, Jiang H, Done SJ, Yaffe MJ. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection. Breast Cancer Research and Treatment. PMID 26518019 DOI: 10.1007/S10549-015-3622-X |
0.375 |
|
| 2015 |
Wright KL, Adams JR, Liu JC, Loch AJ, Wong RG, Jo CE, Beck LA, Santhanam DR, Weiss L, Mei X, Lane TF, Koralov SB, Done SJ, Woodgett JR, Zacksenhaus E, et al. Ras signaling is a key determinant of metastatic dissemination and poor survival of luminal breast cancer patients. Cancer Research. PMID 26400062 DOI: 10.1158/0008-5472.Can-14-2992 |
0.457 |
|
| 2015 |
Liu FF, Shi W, Done SJ, Miller N, Pintilie M, Voduc D, Nielsen TO, Nofech-Mozes S, Chang MC, Whelan TJ, Weir LM, Olivotto IA, McCready DR, Fyles AW. Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 2035-40. PMID 25964246 DOI: 10.1200/Jco.2014.57.7999 |
0.395 |
|
| 2015 |
Dowling RJ, Niraula S, Chang MC, Done SJ, Ennis M, McCready DR, Leong WL, Escallon JM, Reedijk M, Goodwin PJ, Stambolic V. Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study. Breast Cancer Research : Bcr. 17: 32. PMID 25849721 DOI: 10.1186/S13058-015-0540-0 |
0.31 |
|
| 2015 |
Hadad SM, Coates P, Jordan LB, Dowling RJ, Chang MC, Done SJ, Purdie CA, Goodwin PJ, Stambolic V, Moulder-Thompson S, Thompson AM. Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial. Breast Cancer Research and Treatment. 150: 149-55. PMID 25682077 DOI: 10.1007/S10549-015-3307-5 |
0.428 |
|
| 2015 |
Kanwar N, Hu P, Bedard P, Clemons M, McCready D, Done SJ. Identification of genomic signatures in circulating tumor cells from breast cancer International Journal of Cancer. 137: 332-344. PMID 25529931 DOI: 10.1002/Ijc.29399 |
0.481 |
|
| 2015 |
Rahbar R, Lin A, Ghazarian M, Yau HL, Paramathas S, Lang PA, Schildknecht A, Elford AR, Garcia-Batres C, Martin B, Berman HK, Leong WL, McCready DR, Reedijk M, Done SJ, et al. B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity. Cancer Immunology Research. 3: 184-95. PMID 25527357 DOI: 10.1158/2326-6066.Cir-14-0113 |
0.301 |
|
| 2015 |
Lam K, Chan C, Done SJ, Levine MN, Reilly RM. Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumab. Nuclear Medicine and Biology. 42: 78-84. PMID 25459109 DOI: 10.1016/J.Nucmedbio.2014.09.011 |
0.349 |
|
| 2015 |
Chang TE, Warren K, Nair R, Lu TY, Adeoye A, Iakovlev V, Done SJ. Abstract 4747: Genomic alterations in ductal carcinoma in situ compared with Invasive breast cancer: a quantitative real-time PCR study Cancer Research. 75: 4747-4747. DOI: 10.1158/1538-7445.Am2015-4747 |
0.403 |
|
| 2015 |
Liu TY, Chang T, Adeoye A, Shi W, Liang S, Chadwick D, Roehrl MHA, Miller N, Liu F, Done SJ. Abstract 3381: Standardizing the analysis of Ki-67 immunohistochemical assays Cancer Research. 75: 3381-3381. DOI: 10.1158/1538-7445.Am2015-3381 |
0.349 |
|
| 2014 |
Lalani N, Paszat L, Sutradhar R, Thiruchelvam D, Nofech-Mozes S, Hanna W, Slodkowska E, Done SJ, Miller N, Youngson B, Tuck A, Sengupta S, Elavathil L, Chang MC, Jani PA, et al. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast. International Journal of Radiation Oncology, Biology, Physics. 90: 1017-24. PMID 25220719 DOI: 10.1016/J.Ijrobp.2014.07.026 |
0.359 |
|
| 2014 |
Prummel MV, Done SJ, Muradali D, Majpruz V, Brown P, Jiang H, Shumak RS, Yaffe MJ, Holloway CM, Chiarelli AM. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program. Breast Cancer Research and Treatment. 147: 389-99. PMID 25108740 DOI: 10.1007/S10549-014-3088-2 |
0.403 |
|
| 2014 |
Wang DY, Done SJ, Mc Cready DR, Leong WL. Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations. Breast Cancer Research : Bcr. 16: R71. PMID 24996446 DOI: 10.1186/bcr3686 |
0.397 |
|
| 2014 |
Kong I, Narod SA, Taylor C, Paszat L, Saskin R, Nofech-Moses S, Thiruchelvam D, Hanna W, Pignol JP, Sengupta S, Elavathil L, Jani PA, Done SJ, Metcalfe S, Rakovitch E. Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis. Current Oncology (Toronto, Ont.). 21: e96-e104. PMID 24523627 DOI: 10.3747/Co.21.1604 |
0.322 |
|
| 2014 |
Cappello P, Blaser H, Gorrini C, Lin DC, Elia AJ, Wakeham A, Haider S, Boutros PC, Mason JM, Miller NA, Youngson B, Done SJ, Mak TW. Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells. Oncogene. 33: 2375-84. PMID 23708664 DOI: 10.1038/onc.2013.183 |
0.435 |
|
| 2014 |
Harris IS, Blaser H, Moreno J, Treloar AE, Gorrini C, Sasaki M, Mason JM, Knobbe CB, Rufini A, Hallé M, Elia AJ, Wakeham A, Tremblay ML, Melino G, Done S, et al. PTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling. Oncogene. 33: 1047-54. PMID 23435421 DOI: 10.1038/onc.2013.24 |
0.392 |
|
| 2014 |
Abdalla M, Kanwar N, Zhu Y, Nair R, Youngson BJ, Miller NA, Liu T, Done SJ. Abstract 4968: Msi2 directly linked to Hedgehog and Wnt signaling in non-triple negative breast cancer Cancer Research. 74: 4968-4968. DOI: 10.1158/1538-7445.Am2014-4968 |
0.485 |
|
| 2014 |
Lalani N, Paszat L, Nofech-Mozes R, Narod S, Hanna W, Thiruchelvam D, Tuck A, Sengupta S, Elavathil L, Jani P, Done S, Miller N, Youngson B, Bonin M, Rakovitch E. Hypofractionated Radiation Therapy for Ductal Carcinoma in Situ of the Breast International Journal of Radiation Oncology*Biology*Physics. 90: S134-S135. DOI: 10.1016/J.Ijrobp.2014.05.587 |
0.386 |
|
| 2013 |
Rakovitch E, Narod SA, Nofech-Moses S, Hanna W, Thiruchelvam D, Saskin R, Taylor C, Tuck A, Youngson B, Miller N, Done SJ, Sengupta S, Elavathil L, Jani PA, Bonin M, et al. Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis. International Journal of Radiation Oncology, Biology, Physics. 86: 491-7. PMID 23708085 DOI: 10.1016/J.Ijrobp.2013.02.031 |
0.348 |
|
| 2013 |
Rakovitch E, Nofech-Mozes S, Narod SA, Hanna W, Thiruchelvam D, Saskin R, Taylor C, Tuck A, Sengupta S, Elavathil L, Jani PA, Done SJ, Miller N, Youngson B, Kong I, et al. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis. Breast Cancer Research and Treatment. 138: 581-90. PMID 23456231 DOI: 10.1007/S10549-013-2455-8 |
0.393 |
|
| 2013 |
Khoumais NA, Scaranelo AM, Moshonov H, Kulkarni SR, Miller N, McCready DR, Youngson BJ, Crystal P, Done SJ. Incidence of breast cancer in patients with pure flat epithelial atypia diagnosed at core-needle biopsy of the breast. Annals of Surgical Oncology. 20: 133-8. PMID 23064777 DOI: 10.1245/s10434-012-2591-0 |
0.398 |
|
| 2013 |
Abdalla M, Nair R, Kanwar N, Holzapfel N, Moreno JC, Done SJ. Abstract 1814: Characterization of the MSI2 gene on 17q22-24.2 and its role in Breast Cancer. Cancer Research. 73: 1814-1814. DOI: 10.1158/1538-7445.Am2013-1814 |
0.515 |
|
| 2013 |
Adeoye AO, Youngson BJ, Miller N, Done SJ. Abstract 1204: Heterogeneity within triple-negative breast cancer (TNBC). Cancer Research. 73: 1204-1204. DOI: 10.1158/1538-7445.Am2013-1204 |
0.493 |
|
| 2013 |
Kanwar N, Done SJ. Metastatic determinants: Breast tumour cells in circulation Cell and Molecular Biology of Breast Cancer. 191-209. DOI: 10.1007/978-1-62703-634-4_10 |
0.37 |
|
| 2012 |
Niraula S, Dowling RJ, Ennis M, Chang MC, Done SJ, Hood N, Escallon J, Leong WL, McCready DR, Reedijk M, Stambolic V, Goodwin PJ. Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study. Breast Cancer Research and Treatment. 135: 821-30. PMID 22933030 DOI: 10.1007/S10549-012-2223-1 |
0.442 |
|
| 2012 |
Quail DF, Walsh LA, Zhang G, Findlay SD, Moreno J, Fung L, Ablack A, Lewis JD, Done SJ, Hess DA, Postovit LM. Embryonic protein nodal promotes breast cancer vascularization. Cancer Research. 72: 3851-63. PMID 22855743 DOI: 10.1158/0008-5472.Can-11-3951 |
0.514 |
|
| 2012 |
Fasih A, Fonge H, Cai Z, Leyton JV, Tikhomirov I, Done SJ, Reilly RM. ¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer. Breast Cancer Research and Treatment. 135: 189-200. PMID 22736376 DOI: 10.1007/S10549-012-2137-Y |
0.35 |
|
| 2012 |
Xu C, Tran-Thanh D, Ma C, May K, Jung J, Vecchiarelli J, Done SJ. Mitochondrial D310 mutations in the early development of breast cancer. British Journal of Cancer. 106: 1506-11. PMID 22472881 DOI: 10.1038/bjc.2012.74 |
0.318 |
|
| 2012 |
Cawthorn TR, Moreno JC, Dharsee M, Tran-Thanh D, Ackloo S, Zhu PH, Sardana G, Chen J, Kupchak P, Jacks LM, Miller NA, Youngson BJ, Iakovlev V, Guidos CJ, Vallis KA, ... ... Done SJ, et al. Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival. Plos One. 7: e30992. PMID 22363530 DOI: 10.1371/journal.pone.0030992 |
0.417 |
|
| 2012 |
Rakovitch E, Nofech-Mozes S, Narod S, Hanna W, Saskin R, Tuck A, Sengupta S, Done S, Miller N, Youngson B, Paszat LF. Long-term rates of breast cancer in a population of women with ductal carcinoma in situ treated by breast-conserving surgery. Journal of Clinical Oncology. 30: 1123-1123. DOI: 10.1200/Jco.2012.30.15_Suppl.1123 |
0.431 |
|
| 2012 |
Niraula S, Dowling RJ, Enis M, Chang M, Done S, Hood N, Escallon J, Leong W, McCready DR, Reedijk M, Stambolic V, Goodwin PJ. Metformin in early breast cancer (BC): A prospective, open-label, neoadjuvant “window of opportunity” study. Journal of Clinical Oncology. 30: 1019-1019. DOI: 10.1200/Jco.2012.30.15_Suppl.1019 |
0.384 |
|
| 2012 |
Kanwar N, Hu P, Clemons M, McCready D, Done S. Abstract 3410: Identification of frequently gained genomic regions in breast circulating tumor cells Cancer Research. 72: 3410-3410. DOI: 10.1158/1538-7445.Am2012-3410 |
0.478 |
|
| 2012 |
Shi W, Fyles A, Pintilie M, Done S, Miller N, Wong D, Olivotto IA, Weir L, McCready DR, Liu F. Abstract 1032: Post-menopausal women with luminal A subtype might not require breast radiotherapy: Preliminary results from a randomized clinical trial of tamoxifen + radiation Cancer Research. 72: 1032-1032. DOI: 10.1158/1538-7445.Am2012-1032 |
0.498 |
|
| 2012 |
Dowling R, Niraula S, Chang M, Done S, Ennis M, Hood N, McCready, Leong W, Escallon J, Reedijk M, Goodwin P, Stambolic V. Abstract PD03-05: Analysis of tumour cell signaling in response to neoadjuvant metformin in women with early stage breast cancer. Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Pd03-05 |
0.365 |
|
| 2012 |
Hadad S, Dowling R, Chang M, Done S, Purdie C, Jordan L, Dewar J, Goodwin P, Stambolic V, Thompson A. Abstract PD03-02: Evidence for the anti-cancer action of metformin mediated via tumor AMPK, Akt and Ki67, in a preoperative window of opportunity trial Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Pd03-02 |
0.458 |
|
| 2012 |
Leong W, Wang D, Done S, McCready D. Abstract P2-10-34: Development and validation of ClinicoMolecular Triad Classification (CMTC), a platform for breast cancer (BC) prognostic and predictive gene signature portfolios. Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P2-10-34 |
0.457 |
|
| 2012 |
Douplik A, Leong WL, Easson AM, Done S, Wilson BC, Shahmoon A, Zalevsky Z. Microendoscopic spectral imaging as a tool for small ductual diagnostics: Preliminary experience Journal of Innovative Optical Health Sciences. 5. DOI: 10.1142/S1793545812500216 |
0.334 |
|
| 2011 |
Wang DY, Done SJ, McCready DR, Boerner S, Kulkarni S, Leong WL. A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis. Breast Cancer Research : Bcr. 13: R92. PMID 21939527 DOI: 10.1186/Bcr3017 |
0.432 |
|
| 2011 |
Sadi AM, Wang DY, Youngson BJ, Miller N, Boerner S, Done SJ, Leong WL. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens. Bmc Cancer. 11: 253:1-13. PMID 21679412 DOI: 10.1186/1471-2407-11-253 |
0.444 |
|
| 2011 |
Hilton JF, Amir E, Hopkins S, Nabavi M, DiPrimio G, Sheikh A, Done SJ, Gianfelice D, Kanji F, Dent S, Barth D, Bouganim N, Al-Najjar A, Clemons M. Acquisition of metastatic tissue from patients with bone metastases from breast cancer. Breast Cancer Research and Treatment. 129: 761-5. PMID 21113656 DOI: 10.1007/S10549-010-1264-6 |
0.3 |
|
| 2011 |
Wang C, Tran-Thanh D, Moreno JC, Cawthorn TR, Jacks LM, Wang DY, McCready DR, Done SJ. Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation. Breast Cancer Research and Treatment. 129: 373-86. PMID 21046228 DOI: 10.1007/S10549-010-1241-0 |
0.485 |
|
| 2011 |
Tran-Thanh D, Arneson NC, Pintilie M, Deliallisi A, Warren KS, Bane A, Done SJ. Amplification of the prolactin receptor gene in mammary lobular neoplasia. Breast Cancer Research and Treatment. 128: 31-40. PMID 20658264 DOI: 10.1007/S10549-010-1025-6 |
0.444 |
|
| 2011 |
Holzapfel N, Nair R, Done SJ. Abstract 2356: Investigating the role of mammalian RNA binding protein Musashi-2 (MSI2) in breast cancer invasion and nodal metastasis Cancer Research. 71: 2356-2356. DOI: 10.1158/1538-7445.Am2011-2356 |
0.446 |
|
| 2010 |
Rashid-Kolvear F, Taboski MA, Nguyen J, Wang DY, Harrington LA, Done SJ. Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells. Bmc Cancer. 10: 390. PMID 20650001 DOI: 10.1186/1471-2407-10-390 |
0.499 |
|
| 2010 |
Costantini DL, McLarty K, Lee H, Done SJ, Vallis KA, Reilly RM. Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenografts. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1084-91. PMID 20554744 DOI: 10.2967/Jnumed.109.072389 |
0.373 |
|
| 2010 |
Williamson D, Dinniwell R, Fung S, Pintilie M, Done SJ, Fyles AW. Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 95: 317-20. PMID 20400190 DOI: 10.1016/J.Radonc.2010.03.021 |
0.445 |
|
| 2010 |
Tran-Thanh D, Buttars S, Wen Y, Wilson C, Done SJ. Cyclooxygenase-2 inhibition for the prophylaxis and treatment of preinvasive breast cancer in a her-2/neu mouse model. Cancer Prevention Research (Philadelphia, Pa.). 3: 202-11. PMID 20103725 DOI: 10.1158/1940-6207.Capr-09-0181 |
0.496 |
|
| 2010 |
Tran-Thanh D, Done SJ. The role of stromal factors in breast tumorigenicity. The American Journal of Pathology. 176: 1072-4. PMID 20093480 DOI: 10.2353/Ajpath.2010.091128 |
0.464 |
|
| 2010 |
Chang H, Mohabir N, Done S, Hamel PA. Loss of ALX4 expression in epithelial cells and adjacent stromal cells in breast cancer. Journal of Clinical Pathology. 62: 908-14. PMID 19783719 DOI: 10.1136/jcp.2009.067298 |
0.329 |
|
| 2010 |
Kwan JY, Wang D, Cawthorn TR, Done SJ. Abstract 3303: Investigation of SPAG5 gene expression as a molecular marker for breast cancer prognosis Cancer Research. 70: 3303-3303. DOI: 10.1158/1538-7445.Am10-3303 |
0.532 |
|
| 2010 |
Kanwar N, Wang C, Clemons M, Done SJ. Abstract 2120: Single cell whole genome amplification for high density SNP analysis of circulating tumor cells in early breast cancer Cancer Research. 70: 2120-2120. DOI: 10.1158/1538-7445.Am10-2120 |
0.488 |
|
| 2010 |
Niraula S, Stambolic V, Dowling R, Ennis M, Chang M, Done S, Hallak S, Hood N, Leong W, Escallon J, Goodwin P. Abstract PD03-06: Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-Pd03-06 |
0.466 |
|
| 2009 |
Broom RJ, Amir E, Cawthorn T, Freedman O, Gianfelice D, Barth D, Galica J, Wang D, Done SJ, Clemons M. Gene expression differences between disseminated tumor cells and tumor cells from overt bone metastases in patients with metastatic breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1040. PMID 27961118 DOI: 10.1200/Jco.2009.27.15_Suppl.1040 |
0.405 |
|
| 2009 |
Wang C, Iakovlev VV, Wong V, Leung S, Warren K, Iakovleva G, Arneson NC, Pintilie M, Miller N, Youngson B, McCready DR, Done SJ. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study. Genes, Chromosomes & Cancer. 48: 1091-101. PMID 19760610 DOI: 10.1002/Gcc.20711 |
0.361 |
|
| 2009 |
Cawthorn TR, Amir E, Broom R, Freedman O, Gianfelice D, Barth D, Wang D, Holen I, Done SJ, Clemons M. Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples. Clinical & Experimental Metastasis. 26: 935-43. PMID 19697143 DOI: 10.1007/S10585-009-9284-5 |
0.365 |
|
| 2009 |
McLarty K, Cornelissen B, Cai Z, Scollard DA, Costantini DL, Done SJ, Reilly RM. Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1340-8. PMID 19617342 DOI: 10.2967/Jnumed.109.062224 |
0.418 |
|
| 2009 |
McLarty K, Cornelissen B, Scollard DA, Done SJ, Chun K, Reilly RM. Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts. European Journal of Nuclear Medicine and Molecular Imaging. 36: 81-93. PMID 18712381 DOI: 10.1007/S00259-008-0923-X |
0.381 |
|
| 2009 |
Amir E, Broom R, Freedman O, Ooi W, Done S, Gianfelice D, Barth D, Kahn H, Clemons M. Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care? Breast Cancer Research. 11. DOI: 10.1186/Bcr2310 |
0.357 |
|
| 2008 |
Wong V, Wang DY, Warren K, Kulkarni S, Boerner S, Done SJ, Leong WL. The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers. Bmc Cancer. 8: 277. PMID 18826606 DOI: 10.1186/1471-2407-8-277 |
0.431 |
|
| 2008 |
Iakovlev VV, Arneson NC, Wong V, Wang C, Leung S, Iakovleva G, Warren K, Pintilie M, Done SJ. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4446-54. PMID 18628458 DOI: 10.1158/1078-0432.Ccr-07-4960 |
0.385 |
|
| 2007 |
Wang C, Navab R, Iakovlev V, Leng Y, Zhang J, Tsao MS, Siminovitch K, McCready DR, Done SJ. Abelson interactor protein-1 positively regulates breast cancer cell proliferation, migration, and invasion. Molecular Cancer Research : McR. 5: 1031-9. PMID 17951403 DOI: 10.1158/1541-7786.Mcr-06-0391 |
0.435 |
|
| 2007 |
McKenna AM, Pintilie M, Youngson B, Done SJ. Quantification of the morphologic features of fibroepithelial tumors of the breast. Archives of Pathology & Laboratory Medicine. 131: 1568-73. PMID 17922594 DOI: 10.1043/1543-2165(2007)131[1568:QOTMFO]2.0.CO;2 |
0.345 |
|
| 2007 |
Ghazani AA, Arneson N, Warren K, Pintilie M, Bayani J, Squire JA, Done SJ. Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization. Neoplasia (New York, N.Y.). 9: 511-20. PMID 17603634 DOI: 10.1593/Neo.07301 |
0.392 |
|
| 2005 |
To MD, Faseruk SA, Gokgoz N, Pinnaduwage D, Done SJ, Andrulis IL. LAF-4 is aberrantly expressed in human breast cancer. International Journal of Cancer. Journal International Du Cancer. 115: 568-74. PMID 15704140 DOI: 10.1002/ijc.20881 |
0.567 |
|
| 2004 |
Cheung AM, Elia A, Tsao MS, Done S, Wagner KU, Hennighausen L, Hakem R, Mak TW. Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice. Cancer Research. 64: 1959-65. PMID 15026330 DOI: 10.1158/0008-5472.Can-03-2270 |
0.347 |
|
| 2001 |
Done SJ, Eskandarian S, Bull S, Redston M, Andrulis IL. p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast. Journal of the National Cancer Institute. 93: 700-4. PMID 11333292 DOI: 10.1093/Jnci/93.9.700 |
0.577 |
|
| 2001 |
Done SJ, Arneson CR, Ozçelik H, Redston M, Andrulis IL. P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers. Breast Cancer Research and Treatment. 65: 111-8. PMID 11261826 |
0.519 |
|
| 1999 |
Khoo US, Ozcelik H, Cheung AN, Chow LW, Ngan HY, Done SJ, Liang AC, Chan VW, Au GK, Ng WF, Poon CS, Leung YF, Loong F, Ip P, Chan GS, et al. Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer. Oncogene. 18: 4643-6. PMID 10467410 DOI: 10.1038/Sj.Onc.1202847 |
0.593 |
|
| 1999 |
Phillips KA, Nichol K, Ozcelik H, Knight J, Done SJ, Goodwin PJ, Andrulis IL. Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations. Journal of the National Cancer Institute. 91: 469-73. PMID 10070948 DOI: 10.1093/Jnci/91.5.469 |
0.552 |
|
| 1998 |
To MD, Done SJ, Redston M, Andrulis IL. Analysis of mRNA from microdissected frozen tissue sections without RNA isolation. The American Journal of Pathology. 153: 47-51. PMID 9665464 DOI: 10.1016/S0002-9440(10)65544-7 |
0.43 |
|
| 1998 |
Done SJ, Arneson NC, Ozçelik H, Redston M, Andrulis IL. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias. Cancer Research. 58: 785-9. PMID 9485035 |
0.489 |
|
| Show low-probability matches. |